Technology | November 11, 2007

Self-Expanding Nitinol Mesh Occlusion Device Receives FDA Nod


AGA Medical Corp. announced today that it has received FDA and European CE Mark approvals for the AMPLATZER Vascular Plug II ("vascular plug II"), a self- expandable nitinol mesh occlusion device designed to be introduced in a minimally invasive fashion through a catheter.
The delivery cable that comes pre-attached to the AMPLATZER Vascular Plug II uses the unique AMPLATZER user interface to enable the physician to position the device in the targeted blood vessel. Once positioned, the cable is unscrewed and the device is released. The vascular plug II is designed with multiple lobes to facilitate rapid clotting and comes in sizes ranging from 3 mm to 22 mm, enabling treatment of a wider range of vessel sizes. Unlike competing devices, a single vascular plug II is generally required to occlude the targeted vessel reportedly making it a cost- and time-effective alternative.


Additional Content

News | Structural Heart Occluders

June 20, 2024 — atHeart Medical, a medical device company establishing a new standard of care for atrial septal defects ...

Home June 20, 2024
Home
News | Structural Heart Occluders

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

Home July 14, 2023
Home
News | Structural Heart Occluders

May 5, 2022 – Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial ...

Home May 05, 2022
Home
News | Structural Heart Occluders

October 4, 2021 — U.S. Food and Drug Administration (FDA) has cleared the Abbott Amplatzer Talisman PFO Occlusion System ...

Home October 04, 2021
Home
Feature | Structural Heart Occluders | By Dave Fornell, Editor

September 20, 2021 — Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Portico ...

Home September 20, 2021
Home
Subscribe Now